Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

[1]  D. Goukassian,et al.  Neovascularization Receptor P75 Is Required in Ischemia-induced Α Tumor Necrosis Factor- Tumor Necrosis Factor-␣ Receptor P75 Is Required in Ischemia-induced Neovascularization , 2007 .

[2]  Michael I Dorrell,et al.  Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. , 2006, The Journal of clinical investigation.

[3]  Katherine B Percarpio,et al.  Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis. , 2006, Chemistry & biology.

[4]  J. Duffield,et al.  Resolvin D Series and Protectin D1 Mitigate Acute Kidney Injury1 , 2006, The Journal of Immunology.

[5]  M. Leduc,et al.  Potential role of microglia in retinal blood vessel formation. , 2006, Investigative ophthalmology & visual science.

[6]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[7]  S. Germain,et al.  Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1–dependent microvascular degeneration , 2005, Nature Medicine.

[8]  Y. Yoon,et al.  The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. , 2005, The Journal of clinical investigation.

[9]  Makoto Arita,et al.  Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Charles N. Serhan,et al.  Molecular circuits of resolution: formation and actions of resolvins and protectins , 2005, The Journal of Immunology.

[11]  T. Shavlakadze,et al.  Silencing TNFα activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice , 2005, Cell and Tissue Research.

[12]  A. Sher,et al.  Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 , 2005, The Journal of experimental medicine.

[13]  Alan W. Stitt,et al.  Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. , 2005, The American journal of pathology.

[14]  J. Sangiovanni,et al.  The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina , 2005, Progress in Retinal and Eye Research.

[15]  Charles N. Serhan,et al.  Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers , 2004, Lipids.

[16]  P. Mukherjee,et al.  Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Kang,et al.  Transgenic mice: Fat-1 mice convert n-6 to n-3 fatty acids , 2004, Nature.

[18]  P. Mukherjee,et al.  Neuroprotectin D 1 : A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress , 2004 .

[19]  W. Forssmann,et al.  Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23 , 2003, FEBS letters.

[20]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[21]  J. Kutok,et al.  Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4). , 2002, The Journal of pharmacology and experimental therapeutics.

[22]  Hee-Yong Kim,et al.  Mechanisms of action of docosahexaenoic acid in the nervous system , 2001, Lipids.

[23]  Richard A. Flavell,et al.  Inhibition of NF-κB Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* , 2000, The Journal of Biological Chemistry.

[24]  R. Sherwin,et al.  Inhibition of NF- k B Activity and Enhancement of Apoptosis by the Neuropeptide Calcitonin Gene-related Peptide* , 2000 .

[25]  K. Costeloe,et al.  Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of preterm babies? , 1997, The American journal of clinical nutrition.

[26]  L. Aiello,et al.  Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Lois E. H. Smith,et al.  Oxygen-induced retinopathy in the mouse. , 1994, Investigative ophthalmology & visual science.

[28]  P. Vassalli,et al.  The pathophysiology of tumor necrosis factors. , 1992, Annual review of immunology.

[29]  P. Baeuerle,et al.  Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.

[30]  S. Fliesler,et al.  Chemistry and metabolism of lipids in the vertebrate retina. , 1983, Progress in lipid research.